---  
layout: startup_page  
title: "GRO Biosciences"  
id: "grobio.com"  
permalink: "/grobiosciencesgrobio.com07192024/"  
website: "https://www.grobio.com/"  
funding_round: "Series B"  
funding_amount: "$60.3M"  
investors: "Atlas Venture, Access Biotechnology, Leaps by Bayer, Redmile Group, Digitalis Ventures, Innovation Endeavors"  
about: "GRO Biosciences leverages synthetic biology to expand the amino acid alphabet and develop protein therapeutics. Its lead program, ProGly-Uricase, targets refractory gout by preventing the formation of anti-drug antibodies. The company's platform is adaptable to various immunogenic therapies and autoimmune diseases."  
markets: "Biotechnology, Pharmaceuticals, Synthetic Biology, Health Diagnostics, Medical, Therapeutics"  
hq: "Boston, Massachusetts, United States"  
founded_year: "2016"  
linkedin: "https://www.linkedin.com/company/grobio/"  
twitter: "https://twitter.com/gro_bio"  
instagram: "https://www.instagram.com/gro_bio/"  
facebook: "https://business.facebook.com/grobio"  
crunchbase: "https://www.crunchbase.com/organization/gro-biosciences-inc"  
pitchbook: ""  

date_display: "19-Jul-2024"  
date: "2024-07-19"

# SEO Optimization  
meta_title: "GRO Biosciences - Series B Funding ($60.3M)"  
meta_description: "GRO Biosciences, GRO Biosciences leverages synthetic biology to expand the amino acid alphabet and develop protein therapeutics. Its lead program, ProGly-Uricase, targ..."  
meta_keywords: "GRO Biosciences, Biotechnology, Pharmaceuticals, Synthetic Biology, Health Diagnostics, Medical, Therapeutics, Series B funding"  
canonical_url: "https://startup.projectstartups.com/grobiosciencesgrobio.com07192024/"  
---